STOCKHOLM, Aug. 20, 2019 /PRNewswire/ -- RaySearch Laboratories AB (publ)"In the second quarter, order intake rose 80 percent and net sales grew 34 percent. Cash flow before financing activities increased to SEK 80 M (-49)"  SECOND QUARTER (APRIL-JUNE 2

BERKELEY, Calif., Aug. 20, 2019 /PRNewswire/ -- Today, the U.S. Patent and Trademark Office has awarded a new patent (U.S. 10,385,360) to the University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering nucleic acid molecules encoding single-mo

SUZHOU, China, Aug. 20, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that an abstract on the company's CS1001-201 trial has been submitted to the upcoming 2019 American Society of Hematology (ASH) Annual Meeting. This will mark the first release of CS1001-201 clinical study data since the trial began.CS1001 is an investigation

TORONTO, Aug. 19, 2019 /PRNewswire/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF)

CLEARWATER, Fla., Aug. 19, 2019 /PRNewswire/ -- Acacia Diversified Holdings, Inc. (ACCA – OTCQB, www.Acaciadiversifiedholdings.com ) is pleased t

MURRAY, Utah, Aug. 19, 2019 /PRNewswire/ -- Earlier this year PPS Data, LLC, a leading healthcare technology provider of 340B and payment reconciliation services for all types of pharmacies, announced the sale of its reconciliation product, ProviderPay, and PPS Data, LLC's impending rebranding. Today PPS Data, LLC announces the complete

BRONX, N.Y., Aug. 19, 2019 /PRNewswire/ -- Members of Albert Einstein College of Medicine's class of 2023 received monogrammed white coats and stethoscopes last week in a ceremony marked with pride and reminders of responsibility as they embark on their lifelong journey of medical education.

LAGUNA HILLS, Calif., Aug. 19, 2019 /PRNewswire/ -- Adagio Medical, Inc. (Adagio), the developer of iCLAS™, the company's ultra-low temperature intelligent continuous lesion ablation system, announced that it has received an Investigational Device Exemption approval with conditions from the US Food and Drug Administration (FD

MARLBOROUGH, Mass., Aug. 19, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) announced the U.S. Food and Drug Administration (FDA) approval of its ImageReady™ MRI labeling for the Vercise Gevia™  Deep Brain Stimulation (DBS) System to be used in a full-body magnetic resonance imaging (MRI) environment.1  This

MEMPHIS, Tenn., Aug. 19, 2019 /PRNewswire/ -- Researchers believe that stuttering – a potentially lifelong and debilitating speech disorder – stems from problems with the circuits in the brain that control speech, but precisely how and where these problems occur is unknown. Using a mouse model of stuttering, scientists report that a loss of cells in the